Evotec ESG Presentation Deck

evotec Werner Lanthaler CEO (since 2009) Craig Johnstone COO (since 2019) PAGE 13 Management team sharing one long-term mission Experienced and international Management Board Experience • 2000-2009 CFO of Intercell AG ● 1998-2000 Director Federation of Austrian Industries • 1995-1998 Senior Management Consultant at McKinsey Board Memberships • AC Immune SA (since 2018) • argenx SE (since 2014) Curexsys GmbH (since 2020) ● Experience • 2015, Directeur General and Site Head, Evotec (France) SAS • 2012-2017, SVP Drug Discovery and Innovation Efficiency; Global Head, Integrated Drug Discovery, Evotec • 1994-2012 Project, function, and leadership roles at AstraZeneca, Prosidion and Rapier Research • Fellow of the Royal Society of Chemistry and Chartered Chemist (FRSC CChem), BSc in Chemistry and a PhD in organic and organometallic synthesis and is an accredited LEAN Sigma Black Belt Enno Spillner CFO (since 2016) Cord Dohrmann CSO (since 2010) Experience • 2013-2016 Chairman of the Management Board, CEO & CFO of 4SC AG ● 2005-2013 CFO of 4SC 1999-2005 Head of Finance and Controlling at BioM AG Board Memberships ● Nanobiotix SA (since 2014) Leon Nanodrugs GmbH (since 2020) ● ● ● Experience 1999-2010 leading DeveloGen from a start-up to an internationally recognised metabolic disease company ● 20 years in biomedical research at leading academic institutions and in the biotech industry Member of the German Science Council (Wissenschaftsrat) (since 2021) Board Memberships Eternygen GmbH (since 2016); FSHD Unlimited (since 2017) Breakpoint Therapeutics (since 2019)

View entire presentation